The ErbB-4 receptor tyrosine kinase homo-and heterodimerizes following heregulin binding, which provokes increased levels of tyrosine autophosphorylation. Unique to the ErbB family, ErbB-4 is then proteolytically cleaved by a-and c-secretase to produce an 80 kDa intracellular domain (s80 ICD) fragment. This fragment is found in both the cytoplasm and nucleus of many normal and cancer cells and can interact with transcription factors in the cytoplasm and nucleus. Since the s80 ICD lacks ectodomain sequences known to play a major role in dimerization of ErbB family members, we asked whether the s80 ICD is an active tyrosine kinase. Here, we demonstrate that the s80 ICD is a constitutively active tyrosine kinase and can form homodimers. The s80 ICD is autophosphorylated in cells and can phosphorylate an exogenous substrate in vitro. Also, the s80 ICD can coassociate and dimers are detected by chemical crosslinking. This is the first example of constitutive kinase activation and dimerization totally within the cytoplasmic domain of an ErbB receptor and suggests that the s80 ICD may function to phosphorylate substrates in the cytoplasm or nucleus.
Recent crystallographic studies of ErbB ectodomains have illuminated the role of an ectodomain dimerization loop as a required element in growth factor initiated dimerization of ErbB family members . However, these results do not allow the conclusion that exposure of the ectodomain dimerization loop is sufficient for dimerization of the intact receptor kinase. There is evidence that sequences within the transmembrane domain and/or cytoplasmic domains may also be involved in the dimerization mechanism of the intact receptors (Chantry, 1995; Murali et al., 1996; Penuel et al., 2002; Stamos et al., 2002; Zhu et al., 2003; Landau et al., 2004; Aifa et al., 2005) .
Within this receptor family only ErbB-4 is subject to a novel two-step proteolysis pathway that is stimulated by binding of the cognate growth factor, heregulin (neuregulin), or the addition of TPA (Vecchi et al., 1996; Zhou and Carpenter, 2000; Ni et al., 2001; Lee et al., 2002) . The initial cleavage occurs within the ErbB-4 ectodomain between His651 and Ser652, placing this cleavage site eight residues outside the transmembrane domain (Cheng et al., 2003) . It seems likely that this cleavage is executed by the transmembrane metalloprotease TACE (ADAM17), as TACE null cells fail to initiate TPA-provoked cleavage (Rio et al., 2000) and recombinant TACE cleaves a peptide representing ErbB-4 residues 646-657 between His651 and Ser652 (Cheng et al., 2003) . In this system, TACE functions as an a-secretase.
The products of ErbB-4 ectodomain cleavage are an ectodomain fragment of 120 kDa and membrane-associated 80 kDa fragment (m80) that begins with Ser652 and includes the transmembrane and cytoplasmic domains of ErbB-4 (Vecchi et al., 1996; Cheng et al., 2003) . The m80 fragment serves as substrate for a second cleavage event that is mediated by the g-secretase component presenilin, a polytopic transmembrane protein, which cleaves substrates within the transmembrane domain. g-Secretase converts the m80 substrate to a product that is designated s80 and is found in the cytosol and nucleus (Ni et al., 2001; Lee et al., 2002) .
The role of the s80 fragment, also termed the intracellular domain (ICD), in biologic responses to heregulin has been investigated recently. The results indicate that in mammary cells this s80 ICD fragment can provoke events associated with differentiation (Williams et al., 2004) . This includes a chaperone function to mediate the nuclear entry of STAT5a and activation of the b-casein promoter. Genetic studies in mice clearly demonstrate that ErbB-4 is required for differentiation in the adult mammary gland (Jones et al., 1999; Long et al., 2003; Tidcombe et al., 2003) as well as neural and heart tissues in the embryo (Gassmann et al., 1995) . The role of ErbB-4 in differentiation is also supported by studies in cell culture systems using mammary cell lines (Sartor et al., 2001) or PC12 cells (Vaskovsky et al., 2000) . Under other conditions the activation of ErbB-4 is known to initiate a cell death response and this is attributable to the s80 ICD in several studies (Ni et al., 2001; Vidal et al., 2005) . Interestingly, nuclear ErbB-4 has been identified in several human tumors (Srinivasan et al., 2000; Junttila et al., 2003; Bei et al., 2004; Hughes et al., 2004; Junttila et al., 2005) and this may represent the s80 ICD. However, relatively little is known about the biochemical properties of the s80 ICD fragment and that is the focus of the studies described herein.
To assess the phosphorylation state of the m80 and s80 ErbB-4 fragments, cDNA constructs encoding these fragments were separately transiently expressed in Cos7 cells. Each construct contained a FLAG epitope at the NH 2 -terminus. The cells were lysed and the fragments precipitated with anti-FLAG. In the case of the m80 fragment, isolation with anti-FLAG assures that the original aminoterminus is retained. It is plausible that some of the m80 fragment may be converted to s80 during expression; however, in that case the FLAG epitope would be removed and the resulting s80 would not be detected. The immunoprecipitates where then blotted with anti-phosphotyrosine to assess the phosphorylation state of each ErbB-4 fragment. The results, presented in Figure 1 clearly show that both m80 and s80 are heavily tyrosine phosphorylated.
The tyrosine phosphorylation of these ErbB-4 fragments could result from autophosphorylation activity or phosphorylation by exogenous tyrosine kinases. For example, Src kinase is known to phosphorylate the cytoplasmic domain of ErbB-1 (Biscardi et al., 1999) . To resolve these possibilities, kinase-deficient K751R mutants of each fragment were expressed and assayed. The results, presented in Figure 1 clearly demonstrate that in the absence of intrinsic kinase activity, both m80 and s80 ErbB-4 fragments are not significantly tyrosine phosphorylated and control blots show that the K751R mutants are expressed at levels equivalent to the wildtype fragments. These results show that the m80 and s80 ErbB-4 fragments are constitutively active tyrosine kinases. This is consistent with data showing that deletion of the ErbB-1 ectodomain results in activation of the membrane-anchored tyrosine kinase (Zhu et al., 2003) . However, the in vivo activity of an ErbB kinase in absence of the transmembrane and ectodomains has not been previously demonstrated.
The above conclusion was tested for the s80 fragment using an in vitro kinase assay with s80 autophosphorylation and phosphorylation of an exogenous substrate measured. The exogenous substrate is a recombinant protein that encodes the central region of PLC-g1 containing two known sites of tyrosine phosphorylation (Chattopadhyay et al., 1999) . These results are presented in Figure 2 and show that under these conditions s80 is autophosphorylated and the exogenous substrate is phosphorylated.
Reports that ErbB-1 cytoplasmic domain interactions exist (Chantry, 1995; Murali et al., 1996; Stamos et al., 2002; Landau et al., 2004; Aifa et al., 2005) and our observation that the m80 fragment of ErbB-4 associates with intact ErbB-2 (Cheng et al., 2003) , led to a test of the capacity of the s80 ICD to self-associate. Cos7 cells were cotransfected with cDNAs that encode the ErbB-4 s80 fragment tagged with FLAG or GFP at the NH 2 -terminus. The cells were lysed, precipitated with anti-FLAG, and blotted with anti-ErbB-4 to distinguish both s80 populations, which differ in molecular mass due to the presence of GFP in one of the constructs. The results shown in Figure 3 demonstrate that when both FLAG s80 and GFP s80 are coexpressed, precipitation with anti-FLAG recovers both forms of s80. As a control for antibody specificity in the initial precipitation, cells were transfected with only GFP s80. This control (lane 3) shows that the recovery of GFP in the anti-Flag precipitate requires coexpression of Flag s80. These data indicate that s80 molecules are constitutively selfassociated, but do not address the oligomerized state.
To determine whether the observed oligomerization of s80 includes dimmers, a crosslinking experiment was performed. Flag s80 was expressed in Cos7 cells and the cells were lysed. The crosslinking agent BS 3 was added to the lysate. Subsequently, anti-FLAG was added, the precipitates subjected to SDS-PAGE, and the s80 species detected by blotting with anti-ErbB-4. The results, shown in Figure 4 , clearly show the presence of of dimers migrating at 160 kDa. That the majority of the s80 molecules is recovered as monomers may reflect the inefficiency of the crosslinking process, the loss of dimers during cell lysis, or that both monomers and dimers coexist in the cells. Figure 1 Tyrosine phosphorylation of ErbB-4 m80 and s80 ICD fragments. Cos7 cells were transfected with the indicated m80 ICD (residues 632-1308, Cyt2 isoform) or s80 ICD (residues 676-1308, Cyt2 isoform) construct containing an aminoterminal FLAG epitope tag. Mutation in the ATP binding site (K751R) was created by site-directed mutagenesis. At 48 hours after transfection, TGH (1% Triton X-100, 10% glycerol, 50 mM HEPES pH 7.2, 10 mM NaCl) lysates were prepared, precipitated with FLAG antibody, and separated by SDS-PAGE. The proteins were transferred to polyvinylidene fluoride membrane and blotted with anti-phosphotyrosine (Santa Cruz PY-99) in the top panel, followed by blotting with anti-ErbB-4 (gift of Dr M Kraus) in the bottom panel.
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Using this dimerization assay, s80 mutations were evaluated to assess what sequences may be required for dimerization. The kinase-negative K751R s80 mutant was able to form dimers as effectively as the wild-type molecules (Figure 4) demonstrating that s80 kinase function is not required for dimerization. This result is not unexpected given what is known about the lack of a kinase domain requirement for the dimerization of intact ErbB receptors. A three residue sequence in the cytoplasmic domain of ErbB-2 and ErbB-4 has been identified as necessary for ligand-dependent transactivation or activation, respectively, of these intact receptors (Penuel et al., 2002) . In ErbB-4 this is the Leu 985 Val 986 Iso 987 sequence located near the end of the kinase domain. We have mutated this sequence to Ala985, 986, 987 and find that it has no influence on dimerization of the ErbB-4 s80 fragment.
That the ErbB-4 ICD exists as a dimeric tyrosine kinase is somewhat unexpected. The crystallographic analysis of the ErbB-1 kinase domain shows that the kinase exists in open configuration, while many other kinase domains exist in closed configuration that requires transphosphorylation, within the context of a dimer, for activation to the open configuration (Stamos et al., 2002) . While we show here that ErbB-4 s80 ICD is an active kinase, it should be noted that we have not quantitatively compared the level of kinase activity between ligand activated ErbB-4 and ectopically expressed s80 ICD.
In the context of dimerization, this same study also identified intermolecular contacts between kinase domains, but noted that these might result from crystal packing. The evidence presented here indicates that the ErbB-4 ICD can adopt a homodimeric state independent of transmembrane or ectodomain sequences. This is in contrast to the analogous EGFR fragment, which does not form dimers under similar conditions (Arteaga et al., 1997) . Therefore, this represents a novel finding within the ErbB family and suggests unique properties of the ErbB-4 ICD. R and were precipitated with anti-ErbB-4 and the immune complexes were used in kinase assays (Vecchi and Carpenter, 1995) in the presence or absence of ATP. As an exogenous substrate a recombinant fragment of PLC-g1 (4 mg) was added to the kinase assay (Chattopadhyay et al. 1999) . After incubating for 15 min at room temperature, the kinase reaction mixture was heated in Laemmli buffer, the proteins separated by SDS-PAGE, and blotted with antiphosphotyrosine (bottom panel) with the arrow indicating the phosphorylated GFP-s80 and PLC-g1 or ErbB-4 antibody (top panel) with the arrow marking the position of unphosphorylated and phosphorylated GFP-s80. (*) Indicates the position of a degredation product of s80. To eliminate nonspecific binding, 40 ml of rec-Protein A Sepharose 4B (Zymed) was added for 30 min at 41C with rocking and then removed by centrifugation (13 000 r.p.m. for 10 min). The precleared lysates were precipitated with 20 ml anti-FLAG-M2-Agarose (Sigma) for 2 h at 41C with rocking. The precipitated agarose complexes were washed 3 times in TGH buffer, separated on a Criterion 4-12% gradient gel (Biorad), and blotted with antiErbB-4. The estimated molecular mass of the s80 dimer (160 kDa) is indicated.
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